Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.355
-0.075 (-5.24%)
At close: Sep 5, 2025, 4:00 PM
1.420
+0.065 (4.80%)
After-hours: Sep 5, 2025, 6:19 PM EDT
Sunshine Biopharma Employees
Sunshine Biopharma had 52 employees as of December 31, 2024. The number of employees increased by 8 or 18.18% compared to the previous year.
Employees
52
Change (1Y)
8
Growth (1Y)
18.18%
Revenue / Employee
$698,880
Profits / Employee
-$121,281
Market Cap
6.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 52 | 8 | 18.18% |
| Dec 31, 2023 | 44 | -2 | -4.35% |
| Dec 31, 2022 | 46 | 43 | 1,433.33% |
| Dec 31, 2021 | 3 | 0 | - |
| Dec 31, 2020 | 3 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SBFM News
- 2 months ago - Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market - Accesswire
- 3 months ago - Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market - Accesswire
- 4 months ago - Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year - Accesswire
- 4 months ago - Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market - Accesswire
- 4 months ago - Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion - Accesswire
- 5 months ago - Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - Accesswire
- 5 months ago - Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - Accesswire
- 5 months ago - Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga